| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SOLUTION / TOPICAL | | 11 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | OINTMENT / TOPICAL | | 11 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | ENEMA / RECTAL | 0.44 %v/v | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SUSPENSION/ DROPS / OPHTHALMIC | 0.45 %w/v | | Exact identifier — unii candidate 34 equally ranked IID candidates |
| OCTOXYNOL 9 | OCTOXYNOL-9 | 7JPC6Y25QS | SPONGE / TOPICAL | 5 %w/w | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| OCTOXYNOL 9 | OCTOXYNOL-9 | 7JPC6Y25QS | SPONGE / TOPICAL | 5 %w/w | | Exact identifier — unii candidate 6 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SUSPENSION / ORAL | | 64 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SUSPENSION/ DROPS / OPHTHALMIC | 0.45 %w/v | | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SUSPENSION/ DROPS / TOPICAL | 0.4 %w/v | | Exact identifier — unii candidate 34 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | ENEMA / RECTAL | 0.02 %w/w | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | LOTION / TOPICAL | 0.3 %w/w | | Exact identifier — unii candidate 34 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | ENEMA / RECTAL | 0.44 %v/v | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | TABLET / ORAL | | 8 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / TRANSDERMAL | | 19 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / OPHTHALMIC | | 2 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | LOTION / TOPICAL | 0.3 %w/w | | Exact identifier — unii candidate 34 equally ranked IID candidates |
| OCTOXYNOL 9 | OCTOXYNOL-9 | 7JPC6Y25QS | GEL / TOPICAL | | 2 mg | Exact identifier — unii candidate 6 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | TABLET / BUCCAL | | 19 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | TABLET, EXTENDED RELEASE / ORAL | | 180 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / TRANSDERMAL | | 19 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| OCTOXYNOL 9 | OCTOXYNOL-9 | 7JPC6Y25QS | GEL / TOPICAL | | 2 mg | Exact identifier — unii candidate 6 equally ranked IID candidates |
| OCTOXYNOL 9 | OCTOXYNOL-9 | 7JPC6Y25QS | LOTION / TOPICAL | | 5 mg | Exact identifier — unii candidate 6 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | OINTMENT / TOPICAL | | 11 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / TOPICAL | | 81 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| OCTOXYNOL 9 | OCTOXYNOL-9 | 7JPC6Y25QS | LOTION / TOPICAL | | 5 mg | Exact identifier — unii candidate 6 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | TABLET / ORAL | | 8 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SUSPENSION / OPHTHALMIC | | 1 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SUSPENSION / OPHTHALMIC | | 1 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | | 440 mg | Exact identifier — unii+route 2 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / TOPICAL | | 81 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SOLUTION / TOPICAL | | 11 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | CAPSULE / ORAL | | 50 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | | 440 mg | Exact identifier — unii+route 2 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | TABLET / BUCCAL | | 19 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / VAGINAL | | 200 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SUSPENSION/ DROPS / TOPICAL | 0.4 %w/v | | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | SUSPENSION / ORAL | | 64 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | CREAM / TOPICAL | | 214 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GRANULE, FOR SUSPENSION / ORAL | | 600 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | TABLET, EXTENDED RELEASE / ORAL | | 180 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | CREAM / TOPICAL | | 214 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GRANULE, FOR SUSPENSION / ORAL | | 600 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | ENEMA / RECTAL | 0.02 %w/w | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | CAPSULE / ORAL | | 50 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / OPHTHALMIC | | 2 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |
| CARBOMER HOMOPOLYMER TYPE B | CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | HHT01ZNK31 | GEL / VAGINAL | | 200 mg | Exact identifier — unii candidate 34 equally ranked IID candidates |